Track the Ambrx Biopharma Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 19 September 2023 (Acquisition). Among the most active insiders: Cormorant Asset Management, LP. The full history is free.
12
Insider Decl.
n/a
Thresholds
€65m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Buys €65mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
250,000 shares@ US$9.95313.6% of flowOrdinary SharesSEC:0000929638-23-000867:0
Canonical exit: 12 Jun 2023 (T+90)
12 of 12 declarations
Acerca de Ambrx Biopharma Inc.
Ambrx Biopharma Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias basadas en proteínas recombinantes. Utiliza tecnología innovadora para diseñar fármacos dirigidos a enfermedades graves.